Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW
10,440
-280 (-2.61%)
Dec 19, 2024, 3:00 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 229.93 billion as of December 20, 2024. Its market cap has decreased by -33.70% in one year.
Market Cap
229.93B
Enterprise Value
183.09B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
10,440.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 229.93B, an increase of 43.49%. That is a compound annual growth rate of 8.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 229.93B | -55.46% |
Dec 28, 2023 | 516.20B | -0.71% |
Dec 29, 2022 | 519.87B | -21.31% |
Dec 30, 2021 | 660.68B | -73.75% |
Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition